Translational and Commercial Applications of Stem Cell-Derived Technologies
Perkins Coie is a proud sponsor of the 19th Wisconsin Stem Cell Symposium, coordinated by the University of Wisconsin–Madison Stem Cell & Regenerative Medicine Center and the BioPharmaceutical Technology Center Institute (BTC Institute). This year’s symposium, titled “Translational and Commercial Applications of Stem Cell-Derived Technologies,” brings together world leaders to present and discuss how these technologies and computational tools are being used to enable diverse translational and commercial biomedical applications.
The information provided is not intended to be a comprehensive review of all developments in the law and practice, or to cover all aspects of those referred to.
Readers should take legal advice before applying it to specific issues or transactions.
Editorial Disclaimer
Originally published before the Ashurst Perkins Coie combination. See disclaimer.